Second Hypertension Drug Recalled Due to Contamination02/11/2018
THURSDAY, Nov. 1, 2018 — Another hypertension drug is being recalled due to contamination that could pose a cancer risk, the U.S. Food and Drug Administration says.
Certain lots of irbesartan are being recalled by SciGen because they contain an industrial chemical that is a suspected carcinogen, CNN reported. The recalled drugs have “Westminster Pharmaceuticals” and “GSMS Inc.” on the label.
Another heart drug, valsartan, was recalled recently due to contamination with possible cancer-causing chemicals, CNN reported.
Not all medicines that contain valsartan or irbesartan are being recalled. The new recall covers only about 1 percent of irbesartan drug products available in the United States, according to the FDA.
FDA Recall Alert
Posted: November 2018
Source: Read Full Article